KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other financing activities (2016 - 2025)

Amgen has reported Other financing activities over the past 17 years, most recently at $57.0 million for Q4 2025.

  • Quarterly results put Other financing activities at $57.0 million for Q4 2025, up 2950.0% from a year ago — trailing twelve months through Dec 2025 was -$52.0 million (up 58.06% YoY), and the annual figure for FY2025 was -$52.0 million, up 58.06%.
  • Other financing activities for Q4 2025 was $57.0 million at Amgen, up from $10.0 million in the prior quarter.
  • Over the last five years, Other financing activities for AMGN hit a ceiling of $57.0 million in Q4 2025 and a floor of -$92.0 million in Q2 2025.
  • Median Other financing activities over the past 5 years was -$26.0 million (2022), compared with a mean of -$21.4 million.
  • Biggest five-year swings in Other financing activities: crashed 221.43% in 2024 and later skyrocketed 2950.0% in 2025.
  • Amgen's Other financing activities stood at $26.0 million in 2021, then crashed by 61.54% to $10.0 million in 2022, then plummeted by 150.0% to -$5.0 million in 2023, then surged by 60.0% to -$2.0 million in 2024, then skyrocketed by 2950.0% to $57.0 million in 2025.
  • The last three reported values for Other financing activities were $57.0 million (Q4 2025), $10.0 million (Q3 2025), and -$92.0 million (Q2 2025) per Business Quant data.